rs141068211

Variant summary

Our verdict is Benign. The variant received -11 ACMG points: 0P and 11B. BP4_ModerateBP6BS1BS2

The NM_177924.5(ASAH1):​c.629T>C​(p.Met210Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00132 in 1,614,240 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: š‘“ 0.00093 ( 0 hom., cov: 32)
Exomes š‘“: 0.0014 ( 2 hom. )

Consequence

ASAH1
NM_177924.5 missense

Scores

8
10

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications P:1U:8B:4

Conservation

PhyloP100: 2.96

Publications

6 publications found
Variant links:
Genes affected
ASAH1 (HGNC:735): (N-acylsphingosine amidohydrolase 1) This gene encodes a member of the acid ceramidase family of proteins. Alternative splicing results in multiple transcript variants, at least one of which encodes a preproprotein that is proteolytically processed. Processing of this preproprotein generates alpha and beta subunits that heterodimerize to form the mature lysosomal enzyme, which catalyzes the degradation of ceramide into sphingosine and free fatty acid. This enzyme is overexpressed in multiple human cancers and may play a role in cancer progression. Mutations in this gene are associated with the lysosomal storage disorder, Farber lipogranulomatosis, and a neuromuscular disorder, spinal muscular atrophy with progressive myoclonic epilepsy. [provided by RefSeq, Oct 2015]
ASAH1 Gene-Disease associations (from GenCC):
  • ASAH1-related sphingolipidosis
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • Farber lipogranulomatosis
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, G2P, Labcorp Genetics (formerly Invitae), Orphanet
  • spinal muscular atrophy-progressive myoclonic epilepsy syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Orphanet, G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -11 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.118029535).
BP6
Variant 8-18062298-A-G is Benign according to our data. Variant chr8-18062298-A-G is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 362376.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.000932 (142/152374) while in subpopulation NFE AF = 0.00176 (120/68034). AF 95% confidence interval is 0.00151. There are 0 homozygotes in GnomAd4. There are 52 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 2 AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_177924.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ASAH1
NM_177924.5
MANE Select
c.629T>Cp.Met210Thr
missense
Exon 8 of 14NP_808592.2Q13510-1
ASAH1
NM_004315.6
c.677T>Cp.Met226Thr
missense
Exon 8 of 14NP_004306.3
ASAH1
NM_001127505.3
c.611T>Cp.Met204Thr
missense
Exon 8 of 14NP_001120977.1Q13510-3

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ASAH1
ENST00000637790.2
TSL:1 MANE Select
c.629T>Cp.Met210Thr
missense
Exon 8 of 14ENSP00000490272.1Q13510-1
ASAH1
ENST00000381733.9
TSL:1
c.677T>Cp.Met226Thr
missense
Exon 8 of 14ENSP00000371152.4Q13510-2
ASAH1
ENST00000314146.10
TSL:1
c.611T>Cp.Met204Thr
missense
Exon 8 of 14ENSP00000326970.10Q13510-3

Frequencies

GnomAD3 genomes
AF:
0.000933
AC:
142
AN:
152256
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000265
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000458
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.0000941
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00176
Gnomad OTH
AF:
0.00144
GnomAD2 exomes
AF:
0.000811
AC:
204
AN:
251450
AF XY:
0.000876
show subpopulations
Gnomad AFR exome
AF:
0.000185
Gnomad AMR exome
AF:
0.000781
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0000462
Gnomad NFE exome
AF:
0.00143
Gnomad OTH exome
AF:
0.00147
GnomAD4 exome
AF:
0.00136
AC:
1989
AN:
1461866
Hom.:
2
Cov.:
31
AF XY:
0.00131
AC XY:
953
AN XY:
727232
show subpopulations
African (AFR)
AF:
0.000329
AC:
11
AN:
33480
American (AMR)
AF:
0.00107
AC:
48
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26134
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39692
South Asian (SAS)
AF:
0.0000232
AC:
2
AN:
86258
European-Finnish (FIN)
AF:
0.0000936
AC:
5
AN:
53416
Middle Eastern (MID)
AF:
0.000173
AC:
1
AN:
5768
European-Non Finnish (NFE)
AF:
0.00165
AC:
1832
AN:
1112000
Other (OTH)
AF:
0.00149
AC:
90
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.466
Heterozygous variant carriers
0
110
220
329
439
549
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
70
140
210
280
350
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000932
AC:
142
AN:
152374
Hom.:
0
Cov.:
32
AF XY:
0.000698
AC XY:
52
AN XY:
74522
show subpopulations
African (AFR)
AF:
0.000264
AC:
11
AN:
41594
American (AMR)
AF:
0.000457
AC:
7
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5188
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4832
European-Finnish (FIN)
AF:
0.0000941
AC:
1
AN:
10632
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00176
AC:
120
AN:
68034
Other (OTH)
AF:
0.00142
AC:
3
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.495
Heterozygous variant carriers
0
9
17
26
34
43
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00130
Hom.:
0
Bravo
AF:
0.000945
TwinsUK
AF:
0.00189
AC:
7
ALSPAC
AF:
0.00311
AC:
12
ESP6500AA
AF:
0.000227
AC:
1
ESP6500EA
AF:
0.00186
AC:
16
ExAC
AF:
0.000667
AC:
81
EpiCase
AF:
0.00131
EpiControl
AF:
0.00202

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
6
2
not provided (8)
-
-
1
ASAH1-related disorders (1)
-
1
-
Farber lipogranulomatosis (1)
-
-
1
Inborn genetic diseases (1)
-
1
-
not specified (1)
1
-
-
Self-limited epilepsy with centrotemporal spikes (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.16
BayesDel_addAF
Benign
-0.10
T
BayesDel_noAF
Uncertain
0.070
CADD
Benign
18
DANN
Uncertain
0.98
DEOGEN2
Uncertain
0.77
D
Eigen
Benign
0.0042
Eigen_PC
Benign
0.15
FATHMM_MKL
Uncertain
0.90
D
LIST_S2
Benign
0.79
T
M_CAP
Benign
0.031
D
MetaRNN
Benign
0.12
T
MetaSVM
Uncertain
-0.23
T
MutationAssessor
Benign
1.4
L
PhyloP100
3.0
PrimateAI
Uncertain
0.66
T
PROVEAN
Uncertain
-2.8
D
REVEL
Uncertain
0.58
Sift
Benign
0.086
T
Sift4G
Benign
0.11
T
Polyphen
0.011
B
Vest4
0.60
MVP
0.87
MPC
0.0029
ClinPred
0.031
T
GERP RS
4.3
PromoterAI
-0.0079
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.58
gMVP
0.93
Mutation Taster
=26/74
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs141068211; hg19: chr8-17919807; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.